AZVUDINE

Clinical trials for AZVUDINE explained in plain language.

Never miss a new study

Get alerted when new AZVUDINE trials appear

Sign up with your email to follow new studies for AZVUDINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill aims to control hepatitis b with dual attack

Disease control Recruiting now

This study tests azvudine tablets in 120 people with chronic hepatitis B to see if the drug can control the virus long-term. The approach combines antiviral action with immune system activation. Participants take the pill daily for 12 months, and researchers monitor viral levels,…

Matched conditions: AZVUDINE

Phase: PHASE3 • Sponsor: Zhigang Ren • Aim: Disease control

Last updated May 26, 2026 03:54 UTC

AZVUDINE

Get alerted when new AZVUDINE trials appear

New pill aims to control hepatitis b with dual attack